Published in Immunol Res on October 01, 2014
Cardiovascular events and intensity of treatment in polycythemia vera. N Engl J Med (2012) 5.87
Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med (2005) 4.57
Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center. Alcohol Clin Exp Res (2013) 2.84
Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study. Blood (2004) 2.64
Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia. Blood (2007) 2.53
Vascular and neoplastic risk in a large cohort of patients with polycythemia vera. J Clin Oncol (2005) 2.50
Management of alcohol dependence in patients with liver disease. CNS Drugs (2013) 2.35
Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol (2009) 2.14
Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial. Alcohol Alcohol (2011) 1.98
Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis). Blood (2012) 1.77
Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera. Blood (2006) 1.76
Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment. World J Gastroenterol (2010) 1.69
Melphalan 200 mg/m(2) versus melphalan 100 mg/m(2) in newly diagnosed myeloma patients: a prospective, multicenter phase 3 study. Blood (2009) 1.65
Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound. J Hepatol (2013) 1.62
Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium. Thromb Haemost (2002) 1.62
Image-enhanced endoscopy with I-scan technology for the evaluation of duodenal villous patterns. Dig Dis Sci (2012) 1.52
Influence of proband's characteristics on the risk for venous thromboembolism in relatives with factor V Leiden or prothrombin G20210A polymorphisms. Blood (2013) 1.39
Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia. Blood (2010) 1.34
The haematocrit and platelet target in polycythemia vera. Br J Haematol (2006) 1.25
Epstein syndrome: another renal disorder with mutations in the nonmuscle myosin heavy chain 9 gene. Hum Genet (2001) 1.15
IgD multiple myeloma a descriptive report of 17 cases: survival and response to therapy. J Exp Clin Cancer Res (2012) 1.13
Postsurgery outcomes in patients with polycythemia vera and essential thrombocythemia: a retrospective survey. Blood (2007) 1.13
Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial. Clin Gastroenterol Hepatol (2010) 1.11
Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. Eur J Epidemiol (2013) 1.09
Rare thromboses of cerebral, splanchnic and upper-extremity veins. A narrative review. Thromb Haemost (2010) 1.07
Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN. Am J Hematol (2012) 1.07
Prevalence of inherited antithrombin, protein C, and protein S deficiencies in portal vein system thrombosis and Budd-Chiari syndrome: a systematic review and meta-analysis of observational studies. J Gastroenterol Hepatol (2013) 1.07
Polymyalgia rheumatica in 2011. Best Pract Res Clin Rheumatol (2012) 1.05
Prevention of thrombosis in polycythemia vera and essential thrombocythemia. Haematologica (2008) 1.01
The role of IL-15 in gastrointestinal diseases: a bridge between innate and adaptive immune response. Cytokine Growth Factor Rev (2013) 1.01
Prophylaxis against venous thromboembolism in patients with cancer. N Engl J Med (2014) 0.97
Platelet activation and inhibition in polycythemia vera and essential thrombocythemia. Blood (2013) 0.94
Cellular mediators of inflammation: tregs and TH17 cells in gastrointestinal diseases. Mediators Inflamm (2010) 0.94
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels. Clin Endocrinol (Oxf) (2012) 0.92
'Doctor, treat your patient, not your monitor!' Tremor-induced ECG artefacts mimicking torsades de pointes. BMJ Case Rep (2014) 0.91
IL-1β biological treatment of familial Mediterranean fever. Clin Rev Allergy Immunol (2013) 0.89
Are MPNs vascular diseases? Curr Hematol Malig Rep (2013) 0.89
Differential diagnosis of pulmonary embolism in outpatients with non-specific cardiopulmonary symptoms. Intern Emerg Med (2011) 0.89
Cerebral sinus-venous thrombosis. Intern Emerg Med (2012) 0.88
Methylenetetrahydrofolate reductase C677T gene mutation and hyperhomocysteinemia in Budd-Chiari syndrome and portal vein thrombosis: A systematic review and meta-analysis of observational studies. Hepatol Res (2014) 0.87
Clopidogrel-induced neutropenia after coronary stenting: is cilostazol a good alternative? Int J Vasc Med (2011) 0.87
Extra-abdominal venous thromboses at unusual sites. Best Pract Res Clin Haematol (2012) 0.86
A case of variant angina in a patient under chronic treatment with sorafenib. Nat Rev Clin Oncol (2010) 0.85
Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet. Clin Transl Gastroenterol (2012) 0.85
Angiogenic impairment of the vascular endothelium: a novel mechanism and potential therapeutic target in muscular dystrophy. Arterioscler Thromb Vasc Biol (2013) 0.85
Viral cirrhosis: an overview of haemostatic alterations and clinical consequences. Mediterr J Hematol Infect Dis (2009) 0.85
Surgical bleeding after pre-operative unfractionated heparin and low molecular weight heparin for coronary bypass surgery. Haematologica (2007) 0.84
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms. Dig Liver Dis (2012) 0.83
Distinct expression of cyclooxygenase-1 and -2 in the human thymus. Eur J Immunol (2002) 0.83
Autoimmune hemolytic anemia with gel-based immunohematology tests. Am J Clin Pathol (2013) 0.83
Screening for thrombophilia and antithrombotic prophylaxis in pregnancy: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Thromb Res (2009) 0.83
Antithrombotic prophylaxis during pregnancy in women with deficiency of natural anticoagulants. Blood Coagul Fibrinolysis (2008) 0.83
Prognostic factors associated with progression of smoldering multiple myeloma to symptomatic form. Cancer (2012) 0.82
NSAID enteropathy: could probiotics prevent it? J Gastroenterol (2012) 0.81
Absence of the JAK2 exon 12 mutations in patients with splanchnic venous thrombosis and without overt myeloproliferative neoplasms. Am J Hematol (2009) 0.81
Prevalence of the JAK2 V617F mutation in patients with unprovoked venous thromboembolism of common sites and without overt myeloproliferative neoplasms. Br J Haematol (2008) 0.81
A case-control study on the effects of the apolipoprotein E genotypes in nonalcoholic fatty liver disease. Mol Biol Rep (2012) 0.81
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII. J Clin Invest (2015) 0.81
Impact of radiotherapy on pain relief and recalcification in plasma cell neoplasms: long-term experience. Strahlenther Onkol (2011) 0.80
Analysis of MTHFR polymorphisms and P16 methylation and their correlation with clinical-biological features of multiple myeloma. Ann Hematol (2006) 0.80
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation. Am J Hematol (2012) 0.79
Effect of fibrinogen concentration and platelet count on the inhibitory effect of abciximab and tirofiban. Thromb Haemost (2003) 0.79
Baseline von Willebrand factor plasma levels and no-reflow phenomenon after primary percutaneous coronary intervention for ST segment elevation myocardial infarction. Int J Cardiol (2009) 0.79
Pathophysiology of thrombosis in myeloproliferative neoplasms. Haematologica (2011) 0.79
TNFRSF11B gene polymorphisms increased risk of peripheral arterial occlusive disease and critical limb ischemia in patients with type 2 diabetes. Acta Diabetol (2014) 0.79
Severe infectious complications in a patient treated with rituximab for idiopathic thrombocytopenic purpura. Ann Hematol (2006) 0.79
Overexpression of the polycythemia rubra vera-1 gene in essential thrombocythemia. J Clin Oncol (2002) 0.79
Evaluation of the prevalence of severe hyperhomocysteinemia in adult patients with thrombosis who underwent screening for thrombophilia. Thromb Res (2013) 0.79
The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia. Thromb Haemost (2008) 0.78
Combined role of the Lewis antigenic system, Chlamydia pneumoniae, and C-reactive protein in unstable angina. J Am Coll Cardiol (2003) 0.78
High prevalence of the JAK2 V617F mutation in patients with extrahepatic portal vein thrombosis. Hepatology (2007) 0.78
Associations of antiphospholipid antibodies with splanchnic vein thrombosis: a systematic review with meta-analysis. Medicine (Baltimore) (2015) 0.78
Abnormal pH-sensing of platelet Na+/H+ exchanger in patients with cardiac syndrome X. Int J Cardiol (2005) 0.78
The interaction between small intestinal bacterial overgrowth and warfarin treatment. Am J Gastroenterol (2009) 0.78
Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms. An European Leukemia Net study. Am J Hematol (2014) 0.78
Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients. Br J Haematol (2012) 0.78
Protein Z g-42a variant and the risk of pregnancy-related venous thromboembolism in a cohort of Italian patients. Thromb Res (2009) 0.77
In vivo and in vitro effects of different anaesthetics on platelet function. Br J Haematol (2004) 0.77
MYH9 spectrum of autosomal-dominant giant platelet syndromes: unexpected association with fibulin-1 variant-D inactivation. Am J Hematol (2003) 0.77
Report of a novel kindred with antithrombin heparin-binding site variant (47 Arg to His): demand for an automated progressive antithrombin assay to detect molecular variants with low thrombotic risk. Thromb Haemost (2007) 0.76
Recurrent venous thrombosis in a patient with haemophilia A and HIV infection. Haematologica (2002) 0.76
Relationship between changes in platelet reactivity and changes in platelet receptor expression induced by physical exercise. Thromb Res (2007) 0.76
Plasma protein oxidation is associated with an increase of procoagulant markers causing an imbalance between pro- and anticoagulant pathways in healthy subjects. Thromb Haemost (2002) 0.75
Cardiovascular Involvement in Erdheim-Chester Disease: A Case Report and Review of the Literature. Medicine (Baltimore) (2015) 0.75
Brugada electrocardiographic findings in an 80-year-old man. BMJ Case Rep (2013) 0.75
The JAK2 V617F mutation in patients with cerebral venous thrombosis: a rebuttal. Thromb Haemost (2008) 0.75
G20210A prothrombin gene variant and clinical outcome in patients with a first acute coronary syndrome. Haematologica (2004) 0.75
Leukocyte Activation in Obese Patients: Effect of Bariatric Surgery. Medicine (Baltimore) (2015) 0.75
Cerebral venous thrombosis and the risk of pregnancy-related recurrent venous thromboembolism. Intern Emerg Med (2010) 0.75
V1-V2-V3-V4 T wave inversion: left or right ventricle? BMJ Case Rep (2013) 0.75
Alcoholic cardiomyopathy. BMJ Case Rep (2013) 0.75
Ethanol injection is highly effective for hepatocellular carcinoma smaller than 2 cm. World J Gastroenterol (2011) 0.75
'Monolateral' superior vena cava syndrome: right internal jugular vein occlusion. BMJ Case Rep (2014) 0.75
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. Lancet (2002) 0.75
In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband. Thromb Haemost (2011) 0.75
Early postoperative obstructive prosthetic mitral valve thrombosis in a patient double heterozygous for factor V Leiden and prothrombin G20210A mutation. Thromb Haemost (2008) 0.75
Obstetric complications and pregnancy-related venous thromboembolism: the effect of low-molecular-weight heparin on their prevention in carriers of factor V Leiden or prothrombin G20210A mutation. Thromb Haemost (2012) 0.75